Trizepatide is a dual GIP and GLP-1 receptor agonist studied for its efficacy in blood sugar regulation and significant weight reduction in laboratory research. It is investigated for its ability to slow gastric emptying and reduce appetite more effectively than single-receptor agonists. Research Chemical: NOT FOR HUMAN CONSUMPTION.